A Study of Single Dose of LP-003 in Healthy Adult Subjects

NCT06604949 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Spontaneous Urticaria

Interventions

DRUG: LP-003 200mg
DRUG: Placebo

Sponsor

Longbio Pharma